Phagocytic uptake of fluorescent stealth and non-stealth solid lipid nanoparticles

International Journal of Pharmaceutics

Volumn 175, Issue 2, 1998, Pages 185-193

  Bocca, Claudia ^a   Caputo, Otto ^a   Cavalli, Roberta ^a   Gabriel, Ludovica ^a   Miglietta, Antonella ^a   Gasco, Maria Rosa ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Colloidal carriers; Macrophages; Phagocytosis uptake; Stealth solid lipid nanoparticles

Indexed keywords

LIPID; MACROGOL; NANOPARTICLE; RHODAMINE B;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FLUORESCENCE; MACROPHAGE; MOUSE; NONHUMAN; PARTICLE SIZE; PHAGOCYTOSIS; PRIORITY JOURNAL; SPECTROFLUOROMETRY;

EID: 0031740427     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(98)00282-8     Document Type: Article

References (22)

1. Attwood D. Colloidal Drug Delivery Systems. 1994;31-71 Marcel Dekker, New York.
2. Bazile D., Prudhomme C., Bassoullet M.T., Marland M., Spenlehauer G., Veillard M. Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. J. Pharm. Sci. 84:1995;493-496.
3. Cavalli R., Caputo O., Carlotti M.E., Trotta M., Scarnecchia C., Gasco M.R. Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles. Int. J. Pharm. 148:1997;47-54.
4. Cavalli R., Bocca C., Miglietta A., Caputo O., Morel S., Gasco M.R. Albumin adsorption on stealth and non-stealth solid lipid nanoparticles. S.T.P. Pharm. Sci. 1998;. (submitted).
5. Domb A.J. Long-acting injectable oxytetracycline lipospheres formulation. Int. J. Pharm. 124:1995;271-275.
6. Gref R., Minimatake Y., Peracchia M.T., Trubetskoy V., Torchilin V., Langer R. Biodegradable long-circulating polymeric nanospheres. Science. 263:1994;1600-1604.
7. Gref R., Domb A., Quellec P., Blunk T., Müller R.H., Verbavatz J.M., Langer R. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv. Drug Delivery Rev. 16:1995;215-233.
8. Illum L., Davis S.S., Wilson C.G., Thomas N.W., Frier M., Hardy J.G. Blood clearence and organ deposition of intravenously administered colloidal paqrticles. The effect of particle size, nature and shape. Int. J. Pharm. 12:1982;135-146.
9. Illum L., Hunneyball I.M., Davis S.S. The effect of hydrophilic coatings on the uptake of colloidal particles by the liver and by peritonela macrophages. Int. J. Pharm. 29:1986;53-65.
10. Illum L., Davis S.S., Müller R.H., Mak E., West P. The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer poloxamine 908. Life Sci. 40:1987;367-370.
11. Klibanov A.L., Maruyama K., Torchilin V.P., Huang L. Amphipatic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 268:1990;235-240.
12. Koppel D.E. Analysis of macromolecular polydispersity in intensity correlation spectroscopy: the method of cumulants. J. Chem. Phys. 57:1972;4814.
13. Moghimi S.H., Hawley A.E., Christy N.M., Gray T., Illum L., Davis S.S. Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the lymph nodes. FEBS Letters. 344:1994;25-30.
14. Moghimi S.M. Mechanism regulating body distribution of nanospheres conditioned with pluronic and tetronic block copolymers. Adv. Drug. Delivery Rev. 16:1995;183-193.
15. Müller R.H. Colloidal carriers for controlled drug delivery and targeting. 1991;CRC Press, Boca Raton, FL.
16. Müller R.H., Rühl D., Lück M., Paulke B.R. Influence of fluorescent labelling of polystyrene particles on phagocytic uptake, surface hydrophobicity and plasma protein adsorption. Pharm. Res. 14:(1):1997;18-24.
17. Perry D.G., Martin W.J. II. Fluorescent liposomes as quantitative markers of phagocytosis by alveolar macrophages. J. Immunol. Methods. 181:1995;269-285.
18. Schwartz C., Mehenert W., Lucks J.S., Müller R.H. Solid lipid nanoparticles (SLN) for controlled drug delivery. I Production, characterization and sterilization. Int. J. Pharm. 88:1992;53-56.
19. Tobio M., Gref R., Sanchez A., Langer R., Alonso M.J. Stealth PLA-PEG nanoparticles as protein carriers for nasal administration. Pharm. Res. 15:1998;270-276.
20. Westesen K., Siekmann B., Koch M.J.H. Investigation on physical state of lipid nanoparticles by synchroton radiation X-ray diffraction. Int. J. Pharm. 93:1993;199-204.
21. Zalipsky S. Chemistry of polyethylene glycol conjugates with biologically active molecules. Adv. Drug Delivery Rev. 16:1995;157-165.
22. Zara G.P., Cavalli R., Fundarò A., Bargoni A., Caputo O., Gasco M.R. Pharmacokinetics of doxorubicin incorporated in solid lipid nanoparticles. J. Pharm. Pharmacol. 1998;. (submitted).